Company Presentation • 15 Nov 2024 14:30
Company Presentation • 15 Aug 2024 14:00
Company Presentation • 06 Jun 2024 21:00
Company Presentation • 15 May 2024 14:00
Company Presentation • 08 Apr 2024 16:10
ENTITY
Pharmaessentia Corp (6446 TT)
Pharmaessentia Corp (6446 TT)
53
Analysis
Health Care • Taiwan
PharmaEssentia Corporation develops and distributes therapeutic products for treatment in human disease. The Company develops drugs to treat hepatitis, chronic myeloid leukemia (CML), essential thrombocythemia (ET), myeloid fibrosis (MF), polycythemia vera (PV), hepatitis and cancer.
more
x